SCHEMBL1849500

SCHEMBL1849500

N#Cc1ccc(NC(=O)[C@H](CN2CC(O)C2)Oc2ncnc3nn(-c4c(Cl)cccc4Cl)cc23)nc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 19/20 0.74
KCNH2 Q12809 18/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1850658 0.96 GCK (0.75) GCKKCNH2
SCHEMBL1847596 0.90 GCK (0.67) GCKKCNH2
SCHEMBL1851894 0.90 GCK (0.73) GCKKCNH2
SCHEMBL1848532 0.89 GCK (0.76) GCKKCNH2
SCHEMBL1848928 0.88 GCK (0.67) GCKKCNH2
SCHEMBL1852061 0.87 GCK (0.66) GCKKCNH2
SCHEMBL1848057 0.86 GCK (0.74) GCKKCNH2
SCHEMBL839221 0.85 GCK (1.00) GCKKCNH2
SCHEMBL1848902 0.84 GCK (0.65) GCKKCNH2
SCHEMBL1847667 0.83 GCK (0.73) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324028-A2 THERAPEUTIC AGENTS 414 AstraZeneca AB (SE) 2011-05-25 EP disclosed
WO-2010015849-A2 THERAPEUTIC AGENTS 414 ASTRAZENECA AB (SE) 2010-02-11 WO disclosed